MUMSS
MRNA icon

Mitsubishi UFJ Morgan Stanley Securities’s Moderna MRNA Stock Holding History

Mitsubishi UFJ Morgan Stanley Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20
Closed -$4K – 132
2022
Q4 		$4K Sell
20
-30
-60% -$4.91K 0.04% 162
2022
Q3 		$6K Hold
50
– – 0.08% 135
2022
Q2 		$7K Hold
50
– – 0.01% 130
2022
Q1 		$9K Sell
50
-756
-94% -$127K 0.01% 121
2021
Q4 		$205K Buy
806
+576
+250% +$168K 0.1% 22
2021
Q3 		$89K Buy
+230
New +$84.8K 0.08% 38

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mitsubishi UFJ Morgan Stanley Securities's MRNA Position: Q1 2023 in Review

Mitsubishi UFJ Morgan Stanley Securities sold out of Moderna (MRNA) in Q1 2023, closing a stake of 20 shares — an estimated $4K sold.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in MRNA in Q3 2021 and held it in 6 quarters. The position peaked at $205K in Q4 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Mitsubishi UFJ Morgan Stanley Securities reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Mitsubishi UFJ Morgan Stanley Securities sold 20 Moderna shares in Q1 2023, an estimated $4K.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in Moderna in Q3 2021 and held it in 6 quarters.
  • Mitsubishi UFJ Morgan Stanley Securities's Moderna position peaked at $205K in Q4 2021.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q1 2023, filed 2 May 2023.